Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alogabat in children and adolescents with Angelman Syndrome
NCT05630066Phase 2Completed
- Sponsor
- Roche
- Start
- Jul 2023
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 2 trial of alogabat in Angelman syndrome (AS), sponsored by Roche. Started Jul 2023; status: completed.
02
Drugs
alogabat
03
Conditions
Angelman syndrome (AS)
Beyond the preview
Go deeper on NCT05630066.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05630066.